tiprankstipranks
Inmune Bio (INMB)
NASDAQ:INMB
US Market
INMB
Inmune Bio
RESEARCH TOOLSreports
Want to see INMB full AI Analyst Report?

Inmune Bio (INMB) Income Statement

879 Followers

Inmune Bio Income Statement

Last quarter (Q4 2025), Inmune Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Inmune Bio's net income was $-5.26M. See Inmune Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 50.00K$ 14.00K$ 155.00K$ 374.00K$ 181.00K
Gross Profit
$ 50.00K$ 14.00K$ 155.00K$ 374.00K$ 181.00K
Operating Expenses
$ 30.92M$ 42.65M$ 29.90M$ 26.32M$ 29.33M
Depreciation and Amortization
$ 84.00K$ 553.00K$ 29.74M$ 25.95M$ 29.15M
EBITDA
$ -30.79M$ -42.08M$ 0.00$ 0.00$ 0.00
Operating Income
$ -30.87M$ -42.63M$ -29.74M$ -25.95M$ -29.15M
Other Income/Expenses
$ -15.06M$ 553.00K$ -267.00K$ -1.35M$ -1.19M
Pretax Income
$ -45.93M$ -42.08M$ -30.01M$ -27.30M$ -30.34M
Net Income
$ -45.93M$ -42.08M$ -30.01M$ -27.30M$ -30.34M
Per Share Metrics
Basic EPS
$ -1.86$ -2.11$ -1.67$ -1.52$ -1.88
Diluted EPS
$ -1.86$ -2.11$ -1.67$ -1.52$ -1.88
Weighted Average Shares Outstanding
 26.59M 19.94M 17.98M 17.93M 16.13M
Weighted Average Shares Outstanding (Diluted)
 26.59M 19.94M 17.98M 17.93M 16.13M
Currency in USD

Inmune Bio Earnings and Revenue History